Sound Financial Strategies Group LLC bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 30,569 shares of the exchange traded fund’s stock, valued at approximately $3,644,000. SPDR S&P Biotech ETF makes up about 2.3% of Sound Financial Strategies Group LLC’s holdings, making the stock its 9th biggest holding.
Other institutional investors also recently modified their holdings of the company. Axiom Investment Management LLC acquired a new position in shares of SPDR S&P Biotech ETF in the first quarter worth $26,000. Financial Life Planners acquired a new stake in SPDR S&P Biotech ETF during the first quarter valued at $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at $27,000. Intesa Sanpaolo Wealth Management purchased a new position in SPDR S&P Biotech ETF in the fourth quarter valued at about $30,000. Finally, SHP Wealth Management purchased a new position in SPDR S&P Biotech ETF in the fourth quarter valued at about $31,000.
SPDR S&P Biotech ETF Price Performance
Shares of XBI stock opened at $160.11 on Wednesday. SPDR S&P Biotech ETF has a fifty-two week low of $88.18 and a fifty-two week high of $165.71. The stock’s 50-day moving average is $151.93 and its two-hundred day moving average is $136.92. The firm has a market cap of $10.46 billion, a P/E ratio of 11.47 and a beta of 0.83.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
